Multiple sclerosis as a painful disease

Area of Science:

• Neurology
• Pain Medicine
• Immunology

Background:

• Pain is a frequent and debilitating symptom for individuals with multiple sclerosis (MS).
• Pain in MS can arise from central neuropathic or peripheral somatic pathology, and may be an initial presentation or herald an exacerbation.
• Chronic pain can develop as a sequela of MS-related nerve damage, affecting pathways like the trigeminal nerve or central sensory structures.

Purpose of the Study:

• To review the diverse causes and pathophysiology of pain in multiple sclerosis.
• To outline current therapeutic strategies for managing pain in MS patients.
• To highlight emerging research directions for novel pain treatments in MS.

Main Methods:

• Literature review of studies on pain in multiple sclerosis.
• Analysis of the pathophysiology linking MS lesions to pain mechanisms.
• Summary of current pharmacological and non-pharmacological treatment modalities.

Main Results:

• Pain in MS involves central/neuropathic or peripheral/somatic origins, with specific presentations like trigeminal neuralgia and Lhermitte's sign.
• Pathophysiology may involve disrupted sensory pathways, abnormal nerve impulses, acquired channelopathies, or glial inflammatory mechanisms.
• Current treatments include antiepileptics, muscle relaxants, anti-inflammatories, and non-pharmacological approaches.

Conclusions:

• Pain management in MS is complex, requiring a multi-faceted approach.
• Cannabis-based treatments show promise, warranting further investigation.
• Targeting glial cell involvement presents a potential avenue for future therapeutic development.